Insight that Drives the Boardroom

Stay ahead with data-backed research, governance analysis, and expert commentary for investors, activists, and corporate leaders.

Activism & Governance

Executive Moves Update – June 11, 2025

Discover this week’s executive moves at Apple, Baxter, Hershey, Akamai, and more—including CEO, CFO, and board changes across U.S. public companies.

Executive Moves Update – June 20, 2025

Track the latest CEO, CFO, and boardroom changes across public companies. This week’s highlights include new leadership at Yum! Brands, GXO Logistics, Athene, and more.

CEO Pay: The $25 Million Plus Pay Club (2025)

Membership in the CEO $25 Million Plus Pay Club keeps growing as does pay for the CEOs. See which CEOs in the club, which shouldn’t be, and which shareholders are coming after.

SPAC & IPO Analysis

Daily SPAC Update – March 19, 2026

SPAC IPOs Slow as BHAV Acquisition’s IPO Makes it Only 6 for March. Integrated Wellness Extension and Voyager + Veraxa Biotech Deal Approved. Quartzsea Deal Terminated.

Daily SPAC Update – March 18, 2026

DMY Squared’s Quantum Deal Approved. Winvest Acquisition Extension Approved. Pelican Deal Vote Delayed. Alphatime Sets Extension Vote. Cayson Goes to Vote.

Daily SPAC Update – March 17, 2026

Harry You’s DMY Squared Deal Vote with Horizon Quantum Today. Pelican Acquisition Deal Vote. Abra and GNQ Insilico Deals Announced. Merlin DeSPAC.

Daily SPAC Update – March 13, 2026

Pono Capital Four Downsized $120M IPO. Inflection Point IV + Merlin Deal Approved. Haymaker 4 + Concrete Partners Deal Vote Today.

Daily SPAC Update – March 12, 2026

Metals Acquisition II IPOs. Inflection Point IV + Merlin and Voyager + VERAXA Deal Votes. Harry You Talks Up Quantum Deal for DMY.

Daily SPAC Update – March 10, 2026

Plum IV + Controlled Thermal Resources and Calisa + GoodVision AI Deals. TLGY + Stabecoin X Assets Deal Vote. DMY Squared PIPE Updates.

Daily SPAC Update – March 9, 2026

Drugs Made in America CEO Lynn Stockwell Terminated after Improper Withdrawals. DMY Squared Increases PIPE. Plum IV $4.7B Deal with CTR.

Get it In Your Inbox

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.